Related Experiment Video
Updated: Jun 7, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
DNA damage-mediated induction of a chemoresistant niche
Luke A Gilbert1, Michael T Hemann
1The Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, 02139, USA.
Abstract:
While numerous cell-intrinsic processes are known to play decisive roles in chemotherapeutic response, relatively little is known about the impact of the tumor microenvironment on therapeutic outcome. Here, we use a well-established mouse model of Burkitt's lymphoma to show that paracrine factors in the tumor microenvironment modulate lymphoma cell survival following the administration of genotoxic chemotherapy. Specifically, IL-6 and Timp-1 are released in the thymus in response to DNA damage, creating a "chemo-resistant niche" that promotes the survival of a minimal residual tumor burden and serves as a reservoir for eventual tumor relapse. Notably, IL-6 is released acutely from thymic endothelial cells in a p38-dependent manner following genotoxic stress, and this acute secretory response precedes the gradual induction of senescence in tumor-associated stromal cells. Thus, conventional chemotherapies can induce tumor regression while simultaneously eliciting stress responses that protect subsets of tumor cells in select anatomical locations from drug action.
Insights
Chemotherapy can trigger tumor microenvironment responses, like IL-6 release, that protect lymphoma cells. This creates a chemo-resistant niche, promoting minimal residual disease and potential relapse.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Cell-intrinsic mechanisms heavily influence chemotherapeutic response.
- The tumor microenvironment's role in therapeutic outcome remains less understood.
Purpose of the Study:
- To investigate how the tumor microenvironment impacts lymphoma cell survival after genotoxic chemotherapy.
- To identify specific factors within the microenvironment that confer chemoresistance.
Main Methods:
- Utilized a mouse model of Burkitt's lymphoma.
- Administered genotoxic chemotherapy to assess treatment effects.
- Analyzed paracrine factor release and cellular responses in the tumor microenvironment.
Main Results:
- Paracrine factors, specifically Interleukin-6 (IL-6) and Tissue Inhibitor of Metalloproteinases-1 (Timp-1), were released in the thymus post-DNA damage.
- These factors created a "chemo-resistant niche," supporting minimal residual tumor cells.
- Acute IL-6 release from thymic endothelial cells, dependent on p38 signaling, preceded stromal cell senescence.
Conclusions:
- Genotoxic chemotherapy can induce tumor regression but also activate protective microenvironmental stress responses.
- These responses shield a subset of tumor cells in specific locations, contributing to relapse potential.
- Targeting microenvironmental interactions is crucial for improving chemotherapy efficacy.
Related Concept Videos
Treatment Resistant Cancers
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Other Unique Bacteria
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

